Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.149,96
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Brainstorm Cell Therapeutics Inc (BCLI) Brainstorm Cell Therapeutics Inc (BCLI) Notizie

BCLI

Brainstorm Cell Therapeu... (BCLI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCLI
DataOraFonteTitoloSimboloCompagnia
07/01/202522:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
07/01/202522:10Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202421:24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
30/09/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
24/09/202422:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
17/09/202421:32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413:03Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
06/08/202422:59Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
05/08/202423:11Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
31/07/202422:09Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
24/07/202414:30PR Newswire (Canada)BCLI Update - Progress Supports Our 10x Plus Value Range PotentialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/06/202418:01PR Newswire (US)BCLI: Initiation - Potential 10x Return on Successful Phase 3b. Promising Post Hoc and Biomarker Analysis Underpins Our NurOwn® Clinical Effectiveness ExpectationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
27/02/202412:30PR Newswire (US)BrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific ConferenceNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
23/02/202412:00PR Newswire (US)BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALSNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
13/02/202412:30PR Newswire (US)BrainStorm Cell Therapeutics to Present at European Life Sciences CEO ForumNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
12/02/202416:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
18/12/202311:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 - (NASDAQ: BCLI)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
22/11/202322:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
27/09/202316:10AllPennyStocks.comBiotech Shares Halted Premarket As FDA Reviews ApplicationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
19/07/202315:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
21/06/202322:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
21/06/202322:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
20/06/202323:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
15/05/202313:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
05/04/202316:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
10/11/202215:44TipRanksBrainstorm Plummets After the FDA Rejects ApplicationNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/09/202218:45TipRanksMaxim Group Remains a Buy on Brainstorm Cell Therapeutics (BCLI)NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCLI

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network